Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001839882-25-012472
Filing Date
2025-02-28
Accepted
2025-02-28 17:31:48
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP treco-form4_022825.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP treco-form4_022825.xml 4 3349
  Complete submission text file 0001839882-25-012472.txt   4943
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE. NEW YORK NY 10022
Business Address
Treco James (Reporting) CIK: 0001766070 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 25692463